Ab Index-Nr. 613-002-00-7

Index-Nr.Internationale chemische BezeichnungEG-Nr.CAS-Nr.EinstufungKennzeichnungbis 30.11.2018: Spezifische Konzentrations-
grenzen,
M-Faktoren
ab 01.12.2018: Spezifische Konzentrations-
grenzen
M-Faktoren und ATE
Anmer-
kungen
Gefahrenklasse, Gefahren-
kategorie und Gefahren-
kodierung
Kodierung der Gefahrenhin-
weise
Piktogramm, Kodierung der SignalworteKodierung der Gefahrenhin-
weise
Kodierung der ergänzenden Gefahren-
merkmale
613-002-00-7pyridine203-809-9110-86-1Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
H225
H332
H312
H302
GHS02
GHS07
Dgr
H225
H332
H312
H302
 (*) 
613-003-00-21,2,3,4-tetranitrocarbazole6202-15-9Expl. 1.1
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H201
H332
H312
H302
GHS01
GHS07
Dgr
H201
H332
H312
H302
   
613-004-00-8crimidine (ISO);
2-chloro-6-methylpyrimidin-4-
yldimethylamine
208-622-6535-89-7Acute Tox. 2 (*)H300GHS06
Dgr
H300   
613-007-00-4desmetryne (ISO);
6-isopropylamino-2-methyl-
amino-4-methylthio-1,3,5-
triazine
213-800-11014-69-3Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410
   
613-008-00-Xdazomet (ISO);
tetrahydro-3,5-dimethyl-
1,3,5-thiadiazine-
2-thione
208-576-7533-74-4Acute Tox. 4 (*)
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H400
H410
GHS07
GHS09
Wng
H302
H319
H410
   
613-009-00-52,4,6-trichloro-1,3,5-triazine;
cyanuric chloride
203-614-9108-77-0Acute Tox. 2 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
H330
H302
H314
H317
GHS06
GHS05
Dgr
H330
H302
H314
H317
EUH014STOT SE 3;
H335: C ≥ 5 %
 
613-010-00-0ametryn (ISO);
N-ethyl-N'-isopropyl-6-(me-
thylthio)-1,3,5-triazine-2,4-
diamine
212-634-7834-12-8Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
 M = 100 
613-011-00-6amitrole (ISO);
1,2,4-triazol-3-ylamine
200-521-561-82-5Repr. 2
STOT RE 2 (*)
Aquatic Chronic 2
H361d
(*)(*)(*)
H373 (*)(*)
H411
GHS08
GHS09
Wng
H361d
(*)(*)(*)
H373 (*)(*)
H411
   
613-012-00-1bentazone (ISO);
3-isopropyl-2,1,3-benzothia-
diazine-4-one-2,2-dioxide
246-585-825057-89-0Acute Tox. 4 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 3
H302
H319
H317
H412
GHS07
Wng
H302
H319
H317
H412
   
613-013-00-7cyanazine (ISO);
2-(4-chloro-6-ethylamino-
1,3,5-triazine-2-
ylamino)-2-methylpropionitrile
244-544-921725-46-2Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
613-014-00-2ethoxyquin(ISO);
6-ethoxy-1,2-dihydro-2,2,4-
trimethylquinoline
202-075-791-53-2Acute Tox. 4 (*)H302GHS07
Wng
H302   
613-015-00-8fenazaflor (ISO);
phenyl 5,6-dichloro-2-trifluoro-
methylbenzimidazole-1-
carboxylate
238-134-914255-88-0Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410
   
613-016-00-3fuberidazole (ISO);
2-(2-furyl)-1H-benzimidazole
223-404-03878-19-1Carc. 2
Acute Tox. 4
STOT RE 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H302
H373 (Herz)
H317
H400
H410
GHS07
GHS08
GHS09
Wng
H351
H302
H373 (Herz)
H317
H410
 M = 1 
613-017-00-9bis (8-hydroxyquinolinium) sulphate205-137-1134-31-6Acute Tox. 4 (*)H302GHS07
Wng
H302   
613-018-00-4morfamquat (ISO);
1,1'-bis(3,5-dimethylmorpho-
linocarbonylmethyl)-4,4'-
bipyridilium ion
7411-47-4Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 3
H302
H319
H335
H315
H412
GHS07
Wng
H302
H319
H335
H315
H412
   
613-019-00-Xthioquinox(ISO);
2-thio-1,3-dithiolo(4,5,b)qui-
noxaline
202-272-893-75-4Acute Tox. 4 (*)H302GHS07
Wng
H302   
613-020-00-5tridemorph (ISO);
2,6-dimethyl-4-tridecyl-
morpholine
246-347-324602-86-6Repr. 1B
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H360D
(*)(*)(*)
H332
H302
H315
H400
H410
GHS08
GHS07
GHS09
Dgr
H360D
(*)(*)(*)
H332
H302
H315
H410
   
613-021-00-0dithianon (ISO);
5,10-dihydro-5,10-dioxo-
naphtho(2,3-b)
(1,4)dithiazine-2,3-dicarbonitrile
222-098-63347-22-6Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
613-022-00-6pyrethrins including cinerins, with the exception of those specified elsewhere in this AnnexAcute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
  A
613-023-00-12-methyl-4-oxo-3-(penta-2,4-
dienyl)cyclopent-2-enyl [1R-[1α[S(*)(Z)],3β]]-chrysanthemate;
pyrethrin I
204-455-8121-21-1Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
   
613-024-00-72-methyl-4-oxo-3-(penta-2,4-
dienyl)cyclopent-2-enyl[1R-
[1α[S(*)(Z)](3β)]]-3-
(3-methoxy-2-methyl-3-
oxoprop-1-enyl)-2,2-
dimethylcyclopropane-
carboxylate;
pyrethrin II
204-462-6121-29-9Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
   
613-025-00-2cinerin I;
3-(but-2-enyl)-2-methyl-4-
oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate
246-948-025402-06-6Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
613-026-00-8cinerin II;
3-(but-2-enyl)-2-methyl-4-
oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-
methyl-3-oxoprop-1-enyl)cy-
clopropanecarboxylate
204-454-2121-20-0Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
613-027-00-3piperidine203-813-0110-89-4Flam. Liq. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Skin Corr. 1B
H225
H331
H311
H314
GHS02
GHS06
GHS05
Dgr
H225
H331
H311
H314
 (*) 
613-028-00-9morpholine203-815-1110-91-8Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
H226
H332
H312
H302
H314
GHS02
GHS05
GHS07
Dg
H226
H332
H312
H302
H314
   
613-029-00-4dichloro-1,3,5-triazinetrione;
dichloroisocyanuric acid
220-487-52782-57-2Ox. Sol. 2
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H272
H302
H319
H335
H400
H410
GHS03
GHS07
GHS09
Dgr
H272
H302
H319
H335
H410
EUH031 T
613-030-00-Xtroclosene potassium; [1]
troclosene sodium [2]
218-828-8 [1]
220-767-7 [2]
2244-21-5 [1]
2893-78-9 [2]
Ox. Sol. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H272
H302
H319
H335
H400
H410
GHS03
GHS07
GHS09
Dgr
H272
H302
H319
H335
H410
EUH031*
STOT SE 3;
H335: C ≥
10 %
EUH031: C ≥
10 %
G
613-030-01-7troclosene sodium, dihydrate220-767-751580-86-0Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H335
H400
H410
GHS07
GHS09
Wng
H302
H319
H335
H410
EUH031  
613-031-00-5symclosene;
trichloroisocyanuric acid;
trichloro-1,3,5-triazinetrion
201-782-887-90-1Ox. Sol. 2
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H272
H302
H319
H335
H400
H410
GHS03
GHS07
GHS09
Dgr
H272
H302
H319
H335
H410
EUH031  
613-032-00-0methyl-2,3,5,6-tetrachloro-4-
pyridylsulphone;
2,3,5,6-tetrachloro-4-(methyl-
sulphonyl)pyridine
236-035-513108-52-6Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Sens. 1
H312
H302
H319
H317
GHS07
Wng
H312
H302
H319
H317
   
613-033-00-62-methylaziridine;
propyleneimine
200-878-775-55-8Flam. Liq. 2
Carc. 1B
Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
Eye Dam. 1
Aquatic Chronic 2
H225
H350
H330
H310
H300
H318
H411
GHS02
GHS06
GHS08
GHS05
GHS09
Dgr
H225
H350
H330
H310
H300
H318
H411
 Carc. 1B; H350: C ≥ 0,01 % 
613-034-00-11,2-dimethylimidazole217-101-21739-84-0Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
H302
H315
H318
GHS05
GHS07
Dgr
H302
H315
H318
   
613-035-00-71-methylimidazole210-484-7616-47-7Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1B
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314
   
613-036-00-22-methylpyridine;
2-picoline
203-643-7109-06-8Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
H226
H332
H312
H302
H319
H335
GHS02
GHS07
Wng
H226
H332
H312
H302
H319
H335
   
613-037-00-84-methylpyridine;
4-picoline
203-626-4108-89-4Flam. Liq. 3
Acute Tox. 3 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H226
H311
H332
H302
H319
H335
H315
GHS02
GHS06
Dgr
H226
H311
H332
H302
H319
H335
H315
   
613-038-00-36-phenyl-1,3,5-triazine-2,4-
diyldiamine;
6-phenyl-1,3,5-triazine-2,4-
diamine;
benzoguanamine
202-095-691-76-9Acute Tox. 4 (*)
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
   
613-039-00-9ethylene thiourea;
imidazolidine-2-thione;
2-imidazoline-2-thiol
202-506-996-45-7Repr. 1B
Acute Tox. 4 (*)
H360D
(*)(*)(*)
H302
GHS08
GHS07
Dgr
H360D
(*)(*)(*)
H302
   
613-040-00-4azaconazole (ISO);
1-{[2-(2,4-dichlorophenyl)-1,3-
dioxolan-2-
yl]methyl}-1H-1,2.4-triazole
262-102-360207-31-0Acute Tox. 4 (*)H302GHS07
Wng
H302   
613-041-00-Xmorpholine-4-carbonyl chloride239-213-015159-40-7Carc. 2
Eye Irrit. 2
Skin Irrit. 2
H351
H319
H315
GHS08
Wng
H351
H319
H315
EUH014  

613-042-00-5
Imazalil (ISO);
1-[2-(Allyloxy)-2-(2,4-
dichlorphenyl)ethyl]-1H-
imidazol
252-615-035554-44-0Carc. 2
Acute Tox. 3
Acute Tox. 4
Eye Dam. 1
Aquatic Chronic 1
H351
H301
H332
H318
H410
GHS08
GHS06
GHS05
GHS09
Dgr
H351
H301
H332
H318
H410
 M = 10 
613-043-00-0imazalil sulphate (ISO) powder;
1- [2-(allyloxy)ethyl-2-(2,4-di-
chlorophenyl)]-1H-imidazo-
lium hydrogen sulphate; [1]
(±)-1- [2-(allyloxy)ethyl-2-
(2,4-di-chlorophenyl)]-1H-
imidazolium hydrogen sulphate [2]
261-351-5 [1]
281-291-3 [2]
58594-72-2 [1]
83918-57-4 [2]
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
   
613-043-01-8imazalil sulphate (ISO), aqueous solution;
1- [2-(allyloxy)ethyl-2-(2,4-di-
chlorophenyl)]-1H-imidazo-
lium hydrogen sulphate; [1]
(±)-1- [2-(allyloxy)ethyl-
2-(2,4-dichlorophenyl)]-1H-
imidazolium hydrogen sulphate [2]
261-351-5 [1]
281-291-3 [2]
58594-72-2 [1]
83918-57-4 [2]
Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H317
H400
H410
GHS05
GHS07
GHS09
Wng
H302
H314
H317
H410
 Skin Corr. 1B;
H314: C ≥ 50 %
Skin Irrit. 2;
H315: 30 % ≤ C < 50 %
Eye Dam. 1;
H318: 15 % ≤ C < 50 %
Eye Irrit. 2; H319:
5 % ≤ C < 15 %
 
613-044-00-6captan (ISO);
1,2,3,6-tetrahydro-N-
(trichloromethylthio)phthalimide
205-087-0133-06-2Carc. 2
Acute Tox. 3 *
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H351
H331
H318
H317
H400
GHS06
GHS05
GHS08
GHS09
Dgr
H351
H331
H318
H317
H400
 M = 10 
613-045-00-1folpet (ISO);
N-(trichloromethylthio)phtha-
limide
205-088-6133-07-3Carc. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H351
H332
H319
H317
H400
GHS08
GHS07
GHS09
Wng
H351
H332
H319
H317
H400
 M = 10 
613-046-00-7captafol (ISO);
1,2,3,6-tetrahydro-N-(1,1,2,2-tetrachloroe-
thylthio)phthalimide
219-363-32425-06-1Carc. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H350
H317
H400
H410
GHS08
GHS09
Dgr
H350
H317
H410
   
613-047-00-21-dimethylcarbamoyl-5-
methylpyrazol-3-yl
dimethylcarbamate;
dimetilan (ISO)
211-420-0644-64-4Acute Tox. 3 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H301
H312
H400
H410
GHS06
GHS09
Dgr
H301
H312
H410
   
613-048-00-8carbendazim (ISO);
methyl benzimidazol-2-ylcarbamate
234-232-010605-21-7Muta. 1B
Repr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H340
H360FD
H400
H410
GHS08
GHS09
Dgr
H340
H360FD
H410
   
613-049-00-3benomyl (ISO);
methyl 1-(butylcarbamoyl)ben-
zimidazol-2-ylcarbamate
241-775-717804-35-2Muta. 1B
Repr. 1B
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H340
H360FD
H335
H315
H317
H400
H410
GHS08
GHS07
GHS09
Dgr
H340
H360FD
H335
H315
H317
H410
 M = 10 
613-050-00-9carbadox (INN);
methyl 3-(quinoxalin-2-yl-
methylene)carba-
zate 1,4-dioxide;
2-(methoxycarbonylhydra-
zonomethyl)qui-
noxaline 1,4-dioxide
229-879-06804-07-5Flam. Sol. 1
Carc. 1B
Acute Tox. 4 (*)
H228
H350
H302
GHS02
GHS08
GHS07
Dgr
H228
H350
H302
  T
613-051-00-4molinate (ISO);
S-ethyl 1-perhydroazepine-
carbothioate;
S-ethyl perhydroazepine-1-
carbothioate
218-661-02212-67-1Carc. 2
Repr. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H361f
(*)(*)(*)
H332
H302
H373 (*)(*)
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H361f
(*)(*)(*)
H332
H302
H373 (*)(*)
H317
H410
 M = 100 
613-052-00-Xtrifenmorph (ISO);
4-tritylmorpholine
215-812-21420-06-0Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
613-053-00-5anilazine (ISO);
2-chloro-N-(4,6-dichloro-
1,3,5-triazin-2-yl)
aniline
202-910-5101-05-3Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H315
H400
H410
GHS07
GHS09
Wng
H319
H315
H410
   
613-054-00-0thiabendazol (ISO);
2-(thiazole-4-yl)benzimidazole
205-725-8148-79-8Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
613-056-00-11,2-dimethyl-3,5-diphenyl-
pyrazolium
methylsulphate;
difenzoquat methyl sulfate
256-152-543222-48-6Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS09
Wng
H302
H410
   
613-057-00-7Dodemorph (ISO);
4-Cyclododecyl-2,6-dimethyl-
morpholin
216-474-91593-77-7Repr. 2
STOT RE 2
Skin Corr. 1C
Skin Sens. 1A
Aquatic Acute 1
Aquatic Chronic 1
H361d
H373 (Leber)
H314
H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H361d
H373 (Leber)
H314
H317
H410
EUH071M = 1
M = 1
 
613-058-00-2permethrin (ISO);
m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-
dimethylcyclopropane-
carboxylate
258-067-952645-53-1Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H332
H302
H317
H400
H410
GHS07
GHS09
Wng
H332
H302
H317
H410
 M = 1000 
613-059-00-8profluralin (ISO);
N-(cyclopropylmethyl)-α, α,α-trifluoro-2,6-
dinitro-N-propyl-p-toluidine
247-656-626399-36-0Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H400
H410
GHS07
GHS09
Wng
H319
H410
   
613-060-00-3resmethrin (ISO);
5-benzyl-3-furylmethyl (±)-cis-trans-
chrysanthemate
233-940-710453-86-8Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
 M = 1000 
613-061-00-96-(1α,5aβ,8aβ,9-penta-
hydroxy-7β-isopropyl-
2β,5β,8β-trimethyl-
perhydro-8bα,9-epoxy-
5,8-ethanocyclopenta[1,2-b]in-
denyl) pyrrole-2-carboxylate;
ryania
239-732-215662-33-6Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410
   
613-062-00-4sabadilla (ISO);
veratrine
8051-02-3Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315
   
613-063-00-Xsecbumeton (ISO);
2-sec-butylamino-4-ethyl-
amino-6-methoxy-
1,3,5-triazine
247-554-126259-45-0Acute Tox. 4 (*)
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H400
H410
GHS07
GHS09
Wng
H302
H319
H410
   
613-064-00-55-(3,6,9-trioxa-2-undecyl-
oxy)benzo(d)-1,3-dioxolane;
sesamex
51-14-9Acute Tox. 4 (*)H302GHS07
Wng
H302   
613-065-00-0simetryn (ISO);
2,4-bis(ethylamino)-6-methyl-
thio-1,3,5-triazine
213-801-71014-70-6Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
613-066-00-6terbumeton (ISO);
2-tert-butylamino-4-ethyl-
amino-6-methoxy-1,3,5-triazine
251-637-833693-04-8Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
613-067-00-1propazine(ISO);
2-chloro-4,6-bis(isopropyl-
amino)-1,3,5-triazine
205-359-9139-40-2Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
   
613-068-00-7atrazine (ISO);
2-chloro-4-ethylamine-6-iso-
propylamine-1,3,5-triazine
217-617-81912-24-9STOT RE 2 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H373 (*)(*)
H317
H400
H410
GHS08
GHS09
Wng
H373 (*)(*)
H317
H410
   
613-069-00-2ε-caprolactam203-313-2105-60-2Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H332
H302
H319
H335
H315
GHS07
Wng
H332
H302
H319
H335
H315
   
613-070-00-8propylenethiourea2122-19-2Repr. 2
Acute Tox. 4 (*)
Aquatic Chronic 3
H361d
(*)(*)(*)
H302
H412
GHS08
GHS07
Wng
H361d
(*)(*)(*)
H302
H412
   
613-071-00-32-fluoro-5-trifluoromethylpyridine400-290-269045-82-5Flam. Liq. 3
Skin Sens. 1
Aquatic Chronic 3
H226
H317
H412
GHS02
GHS07
Wng
H226
H317
H412
   
613-072-00-9N,N-bis(2-ethylhexyl)-((1,2,4-
triazol-1-yl)methyl)amine
401-280-091273-04-0Skin Corr. 1B
Skin Sens. 1
Aquatic Chronic 2
H314
H317
H411
GHS05
GHS07
GHS09
Dgr
H314
H317
H411
   
613-073-00-4N,N-dimethyl-2-(3-(4-chloro-
phenyl)-4,5-dihydropyrazol-1-
ylphenylsulphonyl)ethylamine
401-410-610357-99-0STOT RE 2 (*)
Skin Sens. 1
Aquatic Chronic 2
H373 (*)(*)
H317
H411
GHS08
GHS09
Wng
H373 (*)(*)
H317
H411
   
613-074-00-X3-(3-methylpent-3-yl)isoxazol-
5-ylamine
401-460-982560-06-3Acute Tox. 3 (*)
Acute Tox. 3 (*)
Eye Dam. 1
Aquatic Chronic 3
H331
H301
H318
H412
GHS06
GHS05
Dgr
H331
H301
H318
H412
   
613-075-00-51,3-dichloro-5-ethyl-5-methyl-
imidazolidine-2,4-dione
401-570-789415-87-2Ox. Sol. 1
(*)(*)(*)(*)
Acute Tox. 3 (*)
Skin Corr. 1B
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
H271
H331
H314
H302
H317
H400
GHS03
GHS06
GHS05
GHS09
Dgr
H271
H331
H314
H302
H317
H400
   
613-076-00-03-chloro-5-trifluoromethyl-2-
pyridylamine
401-670-079456-26-1Acute Tox. 4 (*)
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
   
613-077-00-6reaction mass of 5-heptyl-
1,2,4-triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine
401-940-8Acute Tox. 4 (*)
Eye Irrit. 2
Aquatic Chronic 2
H302
H319
H411
GHS07
GHS09
Wng
H302
H319
H411
   
613-078-00-1N,N,N,N-tetrakis(4,6-bis(butyl-
(N-methyl-2,2,6,6-tetramethyl-
piperidin-4-yl)amino)triazin-
2-yl)-4,7-diazadecane-1,10-
diamine
401-990-0106990-43-6Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
613-079-00-74-(1(or 4 or 5 or 6)-methyl-
8,9,10-trinorborn-5-en-2-
yl)pyridine, reaction mass of
isomers
402-520-7Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H315
H317
H400
H410
GHS07
GHS09
Wng
H312
H302
H315
H317
H410
   
613-080-00-23-(bis(2-ethylhexyl)amino-
methyl)benzothia-
zole-2(3H)-thione
402-540-6105254-85-1Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H314
H317
H410
   
613-081-00-81-butyl-2-methylpyridinium bromide402-680-826576-84-1Acute Tox. 4 (*)
Aquatic Chronic 3
H302
H412
GHS07
Wng
H302
H412
   
613-082-00-32-methyl-1-pentylpyridinium bromide402-690-2Acute Tox. 4
((*))
Acute Tox. 4
((*))
Aquatic Chronic 3
H312
H302
H412
GHS07
Wng
H312
H302
H412
   
613-083-00-92-(4-(3-(4-chlorophenyl)-2-
pyrazolin-1-yl)
phenylsulfonyl)ethyldimethyl-
ammonium
formate
402-120-2Skin Corr. 1B
STOT RE 2 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H314
H373 (*)(*)
H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H314
H373 (*)(*)
H317
H410
   
613-084-00-42-(4-(3-(4-chlorophenyl)-4,5-
dihydropyrazolyl)phenyl-
sulphonyl)ethyldimethylammo-
nium hydrogen phosphonate
402-490-5106359-93-7Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H319
H400
H410
GHS07
GHS09
Wng
H319
H410
   
613-085-00-Xreaction mass of
1,1'-(methylenebis(4,1-
phenylene))dipyrrole-2,5-
dione and N-(4-(4-(2,5-dioxopyrrol-1-
yl)benzyl)phenyl)aceta-
mide and 1-(4-(4-(5-oxo-
2H-2-furylidenamino)ben-
zyl)phenyl)pyrrole-2,5-dione
401-970-1Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
(*)
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
613-086-00-5caffeine200-362-158-08-2Acute Tox. 4H302GHS07
Wng
H302   
613-087-00-0tetrahydrothiophene203-728-9110-01-0Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 3
H225
H332
H312
H302
H319
H315
H412
GHS02
GHS07
Dgr
H225
H332
H312
H302
H319
H315
H412
   
613-088-00-61,2-benzisothiazol-3(2H)-one;
1,2-benzisothiazolin-3-one
220-120-92634-33-5Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
H302
H315
H318
H317
H400
GHS05
GHS07
GHS09
Dgr
H302
H315
H318
H317
H400
 Skin Sens. 1;
H317: C ≥ 0,05 %
 
613-089-00-1diquat dibromide; [1]
diquat dichloride; [2]
6,7-dihydrodipyrido[1,2-
α:2',1'-c]pyrazinediylium dihydroxide [3]
201-579-4 [1]
223-714-6 [2]
301-467-6 [3]
85-00-7 [1]
4032-26-2 [2]
94021-76-8 [3]
Acute Tox. 2 (*)
STOT RE 1
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H330
H372 (*)(*)
H302
H319
H335
H315
H317
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H372 (*)(*)
H302
H319
H335
H315
H317
H410
   
613-090-00-7paraquat dichloride;
1,1-dimethyl-4,4'-bipyridinium dichloride; [1]
paraquat dimethylsulfate;
1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate [2]
217-615-7 [1]
218-196-3 [2]
1910-42-5 [1]
2074-50-2 [2]
Acute Tox. 2 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 1
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H330
H311
H301
H372 (*)(*)
H319
H335
H315
H400
H410
GHS06
GHS08
GHS09
Dgr
H330
H311
H301
H372 (*)(*)
H319
H335
H315
H410
   
613-091-00-2morfamquat dichloride; [1]
morfamquat sulfate [2]
225-062-8 [1]
- [2]
4636-83-3 [1]
29873-36-7 [2]
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Chronic 3
H302
H319
H335
H315
H412
GHS07
Wng
H302
H319
H335
H315
H412
   
613-092-00-81,10-phenanthroline200-629-266-71-7Acute Tox. 3 (*)
Aquatic Acute 1
Aquatic Chronic 1
H301
H400
H410
GHS06
GHS09
Dgr
H301
H410
   
613-093-00-3hexasodium
6,13-dichloro-3,10-bis((4-(2,5-
disulfonatoanilino)-6-fluoro
1,3,5-triazin-2-ylamino)prop
3-ylamino)-5,12-dioxa-7,14-
diazapentacene-4,11
disulfonate
400-050-785153-92-0Resp. Sens. 1
Skin Sens. 1
H334
H317
GHS08
Dgr
H334
H317
   
613-094-00-94-methoxy-N,6-dimethyl
1,3,5-triazin-2-ylamine
401-360-55248-39-5Acute Tox. 4 (*)
STOT RE 2 (*)
H302
H373 (*)(*)
GHS08
GHS07
Wng
H302
H373 (*)(*)